Elucidate Revenue and Competitors
Estimated Revenue & Valuation
- Elucidate's estimated annual revenue is currently $7.1M per year.
- Elucidate's estimated revenue per employee is $168,000
Employee Data
- Elucidate has 42 Employees.
- Elucidate grew their employee count by 2% last year.
Elucidate's People
Name | Title | Email/Phone |
---|---|---|
1 | Head People & Culture | Reveal Email/Phone |
2 | Finance and Strategy Project Manager | Reveal Email/Phone |
3 | Lead Data Scientist | Reveal Email/Phone |
4 | Business Development Manager – Financial Crime Risk & Data | Reveal Email/Phone |
Elucidate Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 50 | 32% | N/A | N/A |
#2 | $30.8M | 193 | -14% | N/A | N/A |
#3 | $84M | 480 | 2% | $1.5B | $3.8B |
#4 | $7.1M | 42 | 2% | N/A | N/A |
#5 | $30.9M | 221 | -26% | $64.6M | N/A |
What Is Elucidate?
Elucidate is a financial crime risk management company enabling financial institutions to benchmark and price financial crime risk through the Elucidate FinCrime Index (EFI), an automated platform developed in partnership with leading global correspondent banks. Elucidate is an approved benchmark administrator, authorised by the Federal Financial Supervisory Authority (BaFin) and registered with the European Security and Markets Authority (ESMA).
keywords:N/AN/A
Total Funding
42
Number of Employees
$7.1M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Elucidate News
Pianist Jeremy Denk is a sensitive and articulate polymath who can elucidate his ideas about music with wit, humor, and style.
... have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response...
A multi-omics approach to elucidate the mechanisms of action of a dietary muramidase administered to broiler chickens.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.9M | 42 | 11% | N/A |
#2 | $4.7M | 42 | N/A | N/A |
#3 | $4.4M | 42 | N/A | N/A |
#4 | $6.9M | 42 | N/A | N/A |
#5 | $4.7M | 42 | N/A | N/A |